Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.

@article{Bowen2004CanadianTO,
  title={Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.},
  author={Tom Bowen and Joseph Greenbaum and Yves Charbonneau and Jacques Hebert and Ronald Filderman and Gordon Sussman and Jaime Del Carpio and Milton Gold and Paul Keith and William Moote and Steve Cecchetto and Ollie Cecchetto and Daniel C Sharp and Olivier Broutin and Claude Andr{\'e}},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2004},
  volume={93 5},
  pages={425-30}
}
BACKGROUND Sublingual swallow immunotherapy has been increasingly recognized as a safe and efficacious alternative to parenteral specific immunotherapy. OBJECTIVE To determine the safety and efficacy of sublingual swallow immunotherapy ragweed allergen extract for rhinoconjunctivitis treatment starting just before and continuing through the ragweed pollen season. METHODS This randomized, double-blind, placebo-controlled study was performed in children and adults with a documented history of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology • 2014
View 6 Excerpts

SLIT: indications, follow-up, and management.

Journal of investigational allergology & clinical immunology • 2014
View 1 Excerpt

Safety and tolerability of a short ragweed sublingual immunotherapy tablet.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2014

Similar Papers

Loading similar papers…